الفهرس 
Treatment of Obesity and Bariatric Surgical ProcedureOnly 14 pages are availabe for public view
 |  | from | 134 |  |  |
| | | from | 134 | | |
Abstract
Background: Obesity is a major public health challenge; it is widespread, highly prevalent and has clinical implications with potential negative effects on almost every organ system, as well as being a psychosocial and economic burden. Overweight and obesity, especially abdominal obesity, are associated with type II diabetes, hyperlipidemia, hypertension, coronary heart disease, stroke, peripheral arterial disease and other comorbidities.
Aims: To clarify effect of different bariatric procedures on metabolic comorbidities on obese patients and to asses outcomes, complication and its treatment.
Methodology: Obesity is a major public health challenge; it is widespread, highly prevalent and has clinical implications with potential negative effects on almost every organ system, as well as being a psychosocial and economic burden. Worldwide prevalence of Metabolic Syndrome ranges from <10% to as much as 84%, depending on the region, urban or rural environment, composition (sex, age, race, and ethnicity) of the population studied. It is expected that one-quarter of the world’s adult population has Metabolic Syndrome.
Conclusion: Obesity is usually defined using the body mass index (BMI). Gastric bypass is associated with significant improvement of the cardiovascular risk profile and a decrease in cardiovascular events up to 20 years following gastric bypass surgery was documented.